Wondering if Akeso is still a smart buy after its big run up, or if the best days are already priced in? You are not alone. That is exactly what we are going to unpack. The stock has cooled slightly ...

Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced FDA approval to initiate COMPASSION-37/AK104-311 trial, a global ...

The “Gifting for Seniors” drive has been a yearly holiday event since 2020, but this is the most presents the program has ...

Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced the presentation of a Phase II clinical study that included a longer-term efficacy data evaluating ivonescimab (a PD-1/VEGF bispecific ...

In the midst of regulatory and political upheaval, biopharma’s R&D engine kept running, churning out highs and lows in equal ...

As the holidays approach, be mindful of the risks and rewards surrounding celebrations. With proactive measures and community support, it is possible to enjoy this festive season free from the shadows ...

EAST LIVERPOOL, Ohio (MyValleyTributes) – Fonda R. Moffett, age 63, of East Liverpool, passed away on Friday, December 12, ...

Valinor, a pioneering AI company leveraging advanced machine learning models to increase the probability of clinical trial success by deeply understanding patient response, today announced $13 million ...

The hygiene and health company Essity has appointed Ilham Smaali as Chief Supply Chain Officer. She will take office on December 31, 2025, and will join the company's Executive Management Team. Supply ...

Summit Therapeutics has an incredibly promising cancer candidate in the pipeline. Madrigal Pharmaceuticals made a breakthrough that could drive strong results for years to come. 10 stocks we like ...

Tucatinib addition to trastuzumab and pertuzumab significantly improved PFS in HER2-positive metastatic breast cancer, with a median PFS of 24.9 months versus 16.3 months with placebo. The PFS benefit ...